Project: A novel synergetic approach for increased infection control and reduced device related complications

We will develop a new generation of central venous catheters (CVCs) that will prevent/ delay the development of catheter related blood stream infections (CRBSI) and prevent thrombus formation by providing a safe and effective medical device with in-built anti/non-thrombogenic properties. For the first time, a combination CVC will include a long lasting anti/non-thrombogenic coating with an active fixed biocompatible noble metal surface as a defence against infections and thrombosis formation.

Acronym REDCATH (Reference Number: 9255)
Duration 01/11/2015 - 01/05/2018
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 2

Project partner

Number Name Role Country
20070 Bactiguard AB Coordinator Sweden
20071 BioInteractions Ltd Partner United Kingdom